LEXICON
No.152 March 4, 2016

Special expansion re-pricing (Huge-seller re-pricing)
特例拡大再算定(巨額再算定)

The Ministry of Health, Labor and Welfare (MHLW) will introduce in April 2016 a special expansion re-pricing rule (特例拡大再算定; tokurei kakudai sai santei ), dubbed a “huge-seller” re-pricing rule (巨額再算定; kyogaku sai santei ), which it describes as an extraordinary...

To read the full story

LEXICON

Takeda Pharmaceutical CEO Christophe Weber highlighted the importance of gaining a strong foothold in the world’s largest pharma market at…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…

By Yoshinori Sagehashi

Daiichi Sankyo and GlaxoSmithKline recently announced that they have agreed to dissolve their joint venture company, Japan Vaccine. The failure of this model of joint venture between a major Japanese and foreign drug maker in just six years is disappointing.Over…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…